Shukla Sanjay

CIK 00016710261 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001671026

Recent Transactions

44 trades

Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2026-01-09+1,500,000→ 1,500,000 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common Stock
2025-02-03+10,375→ 146,923 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2025-02-03−10,375→ 10,375 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2025-01-08+1,000,000→ 1,000,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2024-05-31$1.81/sh+20,000→ 136,548 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2024-02-05−10,375→ 20,750 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common stock
2024-02-05+10,375→ 116,548 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2024-01-05+600,000→ 600,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2023-12-12$1.18/sh+12,000→ 106,173 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2023-12-11$1.17/sh+3,000→ 94,173 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2023-11-13$1.11/sh+13,578→ 91,173 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2023-11-10$1.14/sh+1,422→ 77,595 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2023-07-28$2.01/sh+15,000→ 76,173 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2023-02-16+336,096→ 336,096 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2023-02-03−10,375→ 31,125 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common stock
2023-02-03+10,375→ 61,173 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2022-11-21$2.14/sh+10,000→ 50,798 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2022-07-01$2.88/sh+15,000→ 40,798 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2022-05-24+516,280→ 516,280 total
Award
aTYR PHARMA INC$ATYR
Restricted Stock Units
2022-02-03+41,500→ 41,500 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2022-02-03+83,000→ 83,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2022-01-07$6.76/sh+5,000→ 25,798 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2021-11-15$8.57/sh+2,500→ 20,798 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (Right to buy)
2021-05-21+207,000→ 207,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2021-05-18$4.01/sh+10,000→ 18,298 total
Sale
aTYR PHARMA INC$ATYR
Common stock
2021-02-09$7.66/sh−778→ 8,298 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common stock
2021-02-06+1,785→ 9,076 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2021-02-06−1,785→ 0 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2021-02-04+120,000→ 120,000 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2021-02-04+112,469→ 112,469 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2020-06-19$4.27/sh+6,000→ 7,291 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2020-05-26+80,000→ 0 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2020-05-26+73,142→ 73,142 total
Sale
aTYR PHARMA INC$ATYR
Common stock
2020-02-07$4.03/sh−745→ 1,291 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common stock
2020-02-06+1,786→ 2,036 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2020-02-06−1,786→ 1,786 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2020-02-05+39,327→ 39,327 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2019-02-06+200,000→ 200,000 total
Award
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2019-02-06+50,000→ 50,000 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2018-02-06+300,000→ 300,000 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2017-11-01+450,000→ 450,000 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2017-02-07+65,000→ 65,000 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2016-09-13+27,500→ 27,500 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2016-03-30+163,000→ 163,000 total

Companies

aTYR PHARMA INC
Director, President and CEO
$ATYR

Recent Filings

Address

10240 SORRENTO VALLEY ROAD SUITE 300

SAN DIEGO, CA, 92121

View on SEC.gov